Peripheral Artery Disease and Transcatheter Aortic Valve Replacement Outcomes: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Therapy Registry [Structural Heart Disease]

Conclusions— PAD is common among patients undergoing commercial TAVR via transfemoral and nontransfemoral access. Among patients undergoing transfemoral TAVR, PAD is associated with a higher incidence of 1-year adverse outcomes compared with absence of PAD. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT01737528.

http://circinterventions.ahajournals.org/cgi/content/short/10/10/e005456?rss=1

Source: Circulation: Cardiovascular Interventions - October 17, 2017 Category: Cardiology Authors: Fanaroff, A. C., Manandhar, P., Holmes, D. R., Cohen, D. J., Harrison, J. K., Hughes, G. C., Thourani, V. H., Mack, M. J., Sherwood, M. W., Jones, W. S., Vemulapalli, S. Tags: Catheter-Based Coronary and Valvular Interventions, Mortality/Survival, Peripheral Vascular Disease Structural Heart Disease Source Type: research